This observation was in agreement with studies of colorectal and prostatic cancer, in which NDRG1 was reduced in poorly differentiated adenocarcinoma compared to well-differentiated cells (van Belzen et al, 1997; Guan et al, 2000; Caruso et al, 2004). The gene discussed is NDRG1; the disease is prostate carcinoma.